Anuh Pharma Receives WHO Prequalification for Anti-Malarial API

Anuh Pharma Ltd received WHO Prequalification approval for its Amodiaquine Hydrochloride USP Active Pharmaceutical Ingredient.
The approval covers the anti-malarial API manufactured to United States Pharmacopeia (USP) standards for international markets.
This enables the company to supply to WHO-procured and donor-funded global anti-malarial treatment programmes.
The disclosure is made under SEBI Listing Regulations 30 and is available on the company's website.